Pediatr. praxi. 2014;15(2):79-82

Allergic conjunctivitis in children

MUDr.Milan Odehnal, MBA, MUDr.Denisa Petrušková, MUDr.Jiří Malec
Oční klinika dětí a dospělých 2. LF UK a FN v Motole, Praha

Seasonal and perennial conjunctivitis is the most common form of eye allergies. Among the less common but clinically severe allergic

forms, ranks vernal keratoconjunctivitis which is only characteristic for childhood and rare atopic keratoconjunctivitis. Main subjective

symptoms in allergic conjunctivitis is itching, tearing and photophobia. Chemosis of conjunctiva, eyelid swelling and redness of the eye

play a role in clinical diagnosis. Prevention in allergic conjunctivitis is limited. Therapy of allergic conjunctivitis is based on local application

of antihistaminics and mastcell stabilizers. Most optimal are their combination. Chronic conjunctivitis or keratoconjunctivitis severe forms

can lead to anatomical changes such as papillar hypertrophy of conjunctiva or even they can damage the corneal surface. In these cases,

it is necessary to use steroids with the need to monitor the side effects of long-term therapy, including secondary glaucoma and cataract.

Keywords: allergic conjunctivitis, itching, watery eyes, antihistaminics, mast cell stabilizers, corticoids

Published: April 20, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Odehnal M, Petrušková D, Malec J. Allergic conjunctivitis in children. Pediatr. praxi. 2014;15(2):79-82.
Download citation

References

  1. Rosario N, Bielory L. Epidemiology of allergic conjunctivitis. Curr Opin Allergy Clin Immunol. 2011; 11(5): 471-476. Go to original source... Go to PubMed...
  2. Zepeda OB, Rosas VMA, Ito Tsuchiya FM, et al. Allergic conjunctivitis in children. Rev Alerg Mex. 2007; 54: 41-53. Go to PubMed...
  3. Bielory L, Friedlaender MH. Allergic conjunctivitis. Immunol Allergy Clin North Am 2008; 28: 43-58. Go to original source... Go to PubMed...
  4. Brunekreef B, Von Mutius E, Wong G, et al. ISAAC Phase Three Study Group. Exposure to cats and dogs, and symptoms of asthma, rhinoconjunctivitis, and eczema. Epidemiology 2012; 23(5): 742-750. Go to original source... Go to PubMed...
  5. Zicari AM, Nebbioso M, Lollobrigida V, et al. Vernal keratoconjunctivitis: atopy and autoimmunity. Eur Rev Med Pharmacol Sci 2013; 17(10): 1419-1423. Go to PubMed...
  6. Bonini S, Sacchetti M, Mantelli F, Lambiase A. Clinical grading of vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol 2007; 7(5): 436-441. Go to original source... Go to PubMed...
  7. Abelson MB, Granet D. Ocular allergy in pediatric practice. Curr Allergy Asthma Rep 2006; 6: 306-311. Go to original source... Go to PubMed...
  8. Hom MM, Nguyen AL, Bielory L. Allergic conjunctivitis and dry eye syndrome. Ann Allergy Asthma Immunol. 2012; 108(3): 163-166. Go to original source... Go to PubMed...
  9. Haicl P, Černá H. Lokální H1 antihistaminika v terapii akutních alergických reakcí spojivek. Čes. a slov. Oftal., 2004; 1: 58-62.
  10. Boguszaková J, Říhová E, Krásný J. Oční záněty (Farmakoterapie pro praxi), Jessenius Maxdorf, Praha, 2007: 96.
  11. Kim JM, Lin SY, Suarez-Cuervo C, et al. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics 2013; 131(6): 1155-1167. Go to original source... Go to PubMed...
  12. Passalacqua G, Garelli V, Sclif? F, Canonica GW. Sublingual immunotherapy for allergic rhinitis and conjunctivitis. Immunotherapy 2013; 5(3): 257-264. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.